Patriot Financial Group Insurance Agency, LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 214 filers reported holding DENALI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
Patriot Financial Group Insurance Agency, LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$24,000
-17.2%
800
-12.1%
0.01%0.0%
Q1 2022$29,000
-19.4%
910
+12.2%
0.01%
-16.7%
Q4 2021$36,000
+100.0%
811
+125.3%
0.01%
+100.0%
Q3 2021$18,000
-41.9%
360
-9.8%
0.00%
-50.0%
Q2 2021$31,000
+55.0%
399
+14.0%
0.01%
+20.0%
Q1 2021$20,000
-31.0%
3500.0%0.01%
-28.6%
Q4 2020$29,000
+61.1%
350
-30.0%
0.01%
+16.7%
Q3 2020$18,000
-78.8%
500
-85.7%
0.01%
-81.8%
Q2 2020$85,000
-3.4%
3,500
-30.0%
0.03%
-17.5%
Q1 2020$88,000
+3.5%
5,000
+2.0%
0.04%
+25.0%
Q4 2019$85,000
+466.7%
4,900
+390.0%
0.03%
+357.1%
Q3 2019$15,000
-25.0%
1,0000.0%0.01%
-22.2%
Q2 2019$20,000
-4.8%
1,0000.0%0.01%
-18.2%
Q1 2019$21,000
-97.7%
1,000
-97.7%
0.01%
-98.1%
Q4 2018$899,000
-7.0%
43,518
-5.1%
0.59%
+2.6%
Q3 2018$967,000
+16.8%
45,838
-15.6%
0.58%
-34.8%
Q2 2018$828,000
-11.1%
54,305
+9.4%
0.88%
+28.4%
Q1 2018$931,00049,6420.69%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$240,012,00028.78%
Casdin Capital, LLC 1,500,000$48,255,0002.16%
Flagship Pioneering Inc. 2,619,968$84,284,0001.98%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 38,000$8,192,0001.85%
Yiheng Capital Management, L.P. 1,014,684$32,642,0001.49%
SECTORAL ASSET MANAGEMENT INC 207,100$6,662,0001.18%
Artal Group S.A. 600,000$19,302,0000.81%
GILDER GAGNON HOWE & CO LLC 2,619,217$84,260,0000.78%
Temasek Holdings (Private) Ltd 5,369,487$172,736,3970.73%
BRANDYWINE MANAGERS, LLC 9,601$309,0000.53%
View complete list of DENALI THERAPEUTICS INC shareholders